USA: +1 347 690-0211 | UK: +44 2032 894158 | JAPAN: +81 50 5806 9039 | Translate : 

report img

Cancer Gene Therapy Market By Type (Ex-vivo and In-vivo) and By Product (Viral Vectors, Non-viral Vectors, and Others): Global Industry Outlook, Market Size, Business Intelligence, Consumer Preferences, Statistical Surveys, Comprehensive Analysis, Historical Developments, Current Trends, and Forecast 2020–2026

Covid-19

Global Cancer Gene Therapy Market Size, Share

The pandemic continues to cause unprecedented disruption across industries worldwide.Get detailed insights regarding the impact of COVID-19 on the market. Request Sample

Industry Insights

This specialized and expertise oriented industry research report scrutinizes the technical and commercial business outlook of the Cancer gene therapy industry. The report analyzes and declares the historical and current trends analysis of the Cancer gene therapy industry and subsequently recommends the projected trends anticipated to be observed in the Cancer gene therapy market during the upcoming years.

The Cancer gene therapy market report analyzes and notifies the industry statistics at the global as well as regional and country levels in order to acquire a thorough perspective of the entire Cancer gene therapy market. The historical and past insights are provided for FY 2016 to FY 2019 whereas projected trends are delivered for FY 2020 to FY 2026. The quantitative and numerical data is represented in terms of value (USD Million) from FY 2016 – 2026.

The quantitative data is further underlined and reinforced by comprehensive qualitative data which comprises various across-the-board market dynamics. The rationales which directly or indirectly impact the Cancer gene therapy industry are exemplified through parameters such as growth drivers, restraints, challenges, and opportunities among other impacting factors.

Throughout our research report, we have encompassed all the proven models and tools of industry analysis and extensively illustrated all the key business strategies and business models adopted in the Cancer gene therapy industry. The report provides an all-inclusive and detailed competitive landscape prevalent in the Cancer gene therapy market.

The report utilizes established industry analysis tools and models such as Porter’s Five Forces framework to analyze and recognize critical business strategies adopted by various stakeholders involved in the entire value chain of the Cancer gene therapy industry. The Cancer gene therapy market report additionally employs SWOT analysis and PESTLE analysis models for further in-depth analysis.

The report study further includes an in-depth analysis of industry players' market shares and provides an overview of leading players' market position in the Cancer gene therapy sector. Key strategic developments in the Cancer gene therapy market competitive landscape such as acquisitions & mergers, inaugurations of different products and services, partnerships & joint ventures, MoU agreements, VC & funding activities, R&D activities, and geographic expansion among other noteworthy activities by key players of the Cancer gene therapy market are appropriately highlighted in the report.

The cancer gene therapy market was accounted for approximately USD 800 million in 2019. The market is projected to grow at a CAGR of 23% and is anticipated to reach around USD 3,400 million by 2026.

A growing number of cancer patients and increasing geriatric population base are important factors contributing to the growth of the world market in cancer gene therapy. Every year there is an increase in cancer patients worldwide. Cancer is the second leading cause of death in 2016, according to the WHO. It is also believed that one in six deaths was caused by cancer. Another important factor in the prevalence of cancer gene therapy is the increase in R&D activities, owing to significant investments in cancer gene therapy.

The Cancer gene therapy market research report delivers an acute valuation and taxonomy of the Cancer gene therapy industry by practically splitting the market on the basis of different types, applications, and regions. Through the analysis of the historical and projected trends, all the segments and sub-segments were evaluated through the bottom-up approach, and different market sizes have been projected for FY 2020 to FY 2026. The regional segmentation of the Cancer gene therapy industry includes the complete classification of all the major continents including North America, Latin America, Europe, Asia Pacific, and Middle East & Africa. Further, country-wise data for the Cancer gene therapy industry is provided for the leading economies of the world.

The Cancer gene therapy market is segmented based on Type, product and end-user. On the basis of type segmentation, the market is classified into Ex-vivo and In-vivo. In terms of product segmentation, the market is bifurcated into Viral Vectors, Non-viral Vectors, and Others. By End-User, the market is divided into Biopharma companies, Research institutes, and Others.

Some of the essential players operating in the Cancer gene therapy market, but not restricted to include Vigene Biosciences, Sirion Biotech, Bluebird bio, Cellectis, Ziopharm, Cobra, Uniqure, Finvector, Sarepta Therapeutics, and others.

logoThe taxonomy of the Cancer gene therapy industry by its scope and segmentation is as follows:

logoGlobal Cancer gene therapy Market: By Type Segmentation Analysis (Customizable)

  • Ex-vivo
  • In-vivo

logoGlobal Cancer gene therapy Market: By Product Segmentation Analysis (Customizable)

  • Viral Vectors
  • Non-viral Vectors
  • Others

logoGlobal Cancer gene therapy Market: By End-Use Segmentation Analysis (Customizable)

  • Biopharma companies
  • Research institutes
  • Others

logoGlobal Cancer gene therapy Market: Regional Segmentation Analysis (Customizable)

  • North America
    • The U.S.
    • Canada
  • Europe
    • Germany
    • The UK
    • France
    • Spain
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC
    • South Africa
    • Rest of Middle East & Africa

Covid-19

Cancer Gene Therapy Market

The pandemic continues to cause unprecedented disruption across industries worldwide.Get detailed insights regarding the impact of COVID-19 on the market. Request Sample

logoKey Insights from Primary Research

  • As per our primary respondents, the Cancer gene therapy market is set to grow annually at a rate of around 23%.
  • It was established through primary research that the Cancer gene therapy market was valued at around USD 800 million in 2019.
  • After secondary research, we performed face to face interviews to validate our data. The insights interviewee’s declared that Ex-vivo is the most used type for the global cancer gene therapy market.
  • On the basis of the product, the Non-viral Vectors segment dominated the global cancer gene therapy market in 2019. It accounted for around 47% share of the total market in 2019.
  • The Biopharma companies segment, on the basis of end-use segmentation, was the leading revenue-generating category accounting for around 59% share, in 2019.

logoKey Recommendations from Analysts

  • Based on the exhaustive secondary research done by our team, the Ex-vivo type is anticipated to become the most demanding type in the upcoming years, owing to the growing demand for Cancer gene therapy from the medical industry.
  • As per our analysts, North America recorded the highest market share of more than 39% by 2026, and the market is expected to bolster in this region, resulting in creating lucrative opportunities for new players.
  • Growing at a CAGR around 23%, the Cancer gene therapy market provides numerous opportunities for all of the involved stakeholders across the entire value chain.
  • Our analysts have identified Ex-vivo and Non-viral Vectors categories as the leading investment pockets for the Cancer gene therapymarket in terms of type and application segmentation respectively.
  • Our analysts recommend the emerging players to focus on Research institutes owing to the substantial growth of the pharmaceutical and medical industry worldwide.

logoMarket Attractiveness – By Type

logoCancer gene therapy Market

Covid-19

Cancer Gene Therapy Market

The pandemic continues to cause unprecedented disruption across industries worldwide.Get detailed insights regarding the impact of COVID-19 on the market. Request Sample

Industry Major Market Players

  •  Vigene Biosciences
  •  Sirion Biotech
  •  Bluebird bio
  •  Cellectis
  •  Ziopharm
  •  Cobra
  •  Uniqure
  •  Finvector
  •  Sarepta Therapeutics

Frequently Asked Questions

Strict enforcement of laws by government authorities mandating Cancer Gene Therapy Market.
According to Facts and Factors research report, the global Cancer Gene Therapy Market accrued earnings worth approximately XX (USD Billion) in 2020 and is predicted to gain revenue of about XX(USD Billion) by 2028, is set to record a CAGR of nearly XX% over the period from 2021 to 2028.
North America will contribute lucratively towards the global market value over the estimated timeline. The regional market surge is subject to large-scale presence of giant participants in countries such as the U.S. Apart from this, favorable compensation policies along with high acceptance of new Cancer Gene Therapy Market will drive regional market trends. With regional governments enforcing strict laws pertaining to drug abuse, the market for Cancer Gene Therapy Market in North America is set to witness exponential growth over years to come. Legalization of cannabis in countries such as Canada and U.S. through passing of acts in parliament is likely to enlarge scope of Cancer Gene Therapy Market in North America over coming decade.
why choose fnf
key questions answers

Related Reports

report img

Pharmaceutical Market Report 2022 – 2028

[240+ Pages Report] According to Facts and Factors,the pharmaceutical market size was worth USD 1,482.4 million in 2021 and is estimated to grow to USD 2,067.36 million by 2028, with a compound annual growth rate (CAGR) of approximately 5.70% over the forecast period. The report analyzes the pharm...

Published Date : 09-Aug-2022 | | Category : | Pages : 240 | Format : Read more

Inquiry for Buying Request Sample
report img

Oxygen Therapy Market Report 2022 – 2028

[237+ Pages Report] According to Facts and Factors, the global oxygen therapy market size was worth around USD 16,294.10 million in 2021 and is estimated to grow to about USD 28,552.51 million by 2028, with a compound annual growth rate (CAGR) of approximately 9.80% over the forecast period. The r...

Published Date : 09-Aug-2022 | | Category : | Pages : 237 | Format : Read more

Inquiry for Buying Request Sample